KAYATTA, Circuit Judge.
The Food and Drug Administration (FDA) expressed concerns to AVEO Pharmaceuticals about the results of AVEO's clinical trial for tivozanib, a kidney cancer drug candidate. In light of those concerns, the FDA recommended that AVEO conduct another clinical trial. AVEO opted not to disclose that recommendation to the markets...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.